PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gene hastens kidney disease progression in African-Americans

2013-11-09
(Press-News.org) Contact information: Bill Polglase
niddkmedia@mail.nih.gov
301-496-3583
NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Gene hastens kidney disease progression in African-Americans A gene variant common in African-Americans predicts that people with that gene who also have chronic kidney disease (CKD) are twice as likely to progress to kidney failure as African-Americans without the high-risk gene and white people with CKD. People with the high-risk gene also tend to lose kidney function at twice the rate of those without the gene, according to the research, which was funded by the National Institutes of Health.

Investigators from the Chronic Renal Insufficiency Cohort (CRIC) Study and the African American Study of Kidney Disease and Hypertension (AASK) published joint results online today in the New England Journal of Medicine at http://www.nejm.org, which will appear in the Dec. 5, 2013 print issue.

The impact of the gene variant – known as APOL1 – on risk for and rate of CKD progression was consistent in both studies, regardless of whether patients maintained good blood pressure control or had diabetes. High blood pressure and diabetes are major risk factors for CKD and its progression to kidney failure.

"We now know that the APOL1 gene variant is independently associated with a more aggressive course of disease. This finding tells us that different treatment strategies should be studied, so that we may one day delay or prevent kidney failure among people with this genetic risk," said Paul Kimmel, M.D., director of the Kidney Translational Genetics Program at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

"Now that the importance of the gene is known, clinicians could potentially genotype – or map the genes – of African-Americans with CKD to assess their risk for disease progression," said Afshin Parsa, M.D., a nephrologist at the University of Maryland School of Medicine in Baltimore and a CRIC Study investigator. "This discovery provides direct evidence that African-Americans with established CKD and the APOL1 risk gene variant experience a faster decline in kidney function compared to their white counterparts, irrespective in most cases of what caused their kidney disease."

Parsa and Linda Kao, Ph.D., a geneticist from the Johns Hopkins Bloomberg School of Public Health in Baltimore and the AASK Study Group, co-led the research.

The discovery builds on landmark 2008 research by NIH kidney specialist Dr. Jeffrey Kopp and others, led by Dr. Martin Pollak at The Laboratory of Inherited Kidney Disease at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, which found the APOL1 gene variant to be a risk factor for kidney disease that wasn't associated with diabetes.

An estimated 20 million or more American adults have CKD, and over 400,000 people in the United States and 2 million worldwide depend on dialysis to treat kidney failure. Although exceedingly rare in white people, the APOL1 gene variant is found in 13 to15 percent of African-Americans. Some have speculated that it evolved to protect against one of the two forms of African sleeping sickness, a lethal parasitic disease transmitted by the tsetse fly.

The CRIC study is one of the largest and longest ongoing studies of CKD epidemiology in the United States (ClinicalTrials.gov number: NCT00304148). It is supported under NIH grants U01DK060990, U01 DK60980, U01 DK60902, U01 DK61021, U01 DK61022, U01 DK60963, U01 DK61028 and U01 DK60984. CRIC recently embarked on an expansion to add more than 1,500 patients over the next five years, increasing the study's total size to approximately 5,500.

AASK is the largest and longest completed study of chronic kidney disease (CKD) in African-Americans. Beginning as a randomized clinical trial in 1995, the investigation was completed in 2007 as a cohort study.

###

The NIDDK, a component of the NIH, conducts and supports research on diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition and obesity; and kidney, urologic and hematologic diseases. Spanning the full spectrum of medicine and afflicting people of all ages and ethnic groups, these diseases encompass some of the most common, severe and disabling conditions affecting Americans. For more information about the NIDDK and its programs, see http://www.niddk.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

END



ELSE PRESS RELEASES FROM THIS DATE:

Repurposed drug may be first targeted treatment for serious kidney disease

2013-11-09
Repurposed drug may be first targeted treatment for serious kidney disease Treatment with rheumatoid arthritis drug saved transplanted kidney in four patients, achieved remission in a fifth A drug approved for the treatment of rheumatoid arthritis may ...

Universals of conversation

2013-11-09
Universals of conversation Max Planck researchers found that words that signal problems with understanding are similar across languages A word like 'Huh?' —used when one has not caught what someone just said—appears to be universal: it is found to have very ...

High-energy physicists predict new family of four-quark objects

2013-11-09
High-energy physicists predict new family of four-quark objects New charged charmonium-like states observed at BESIII An international team of high-energy physicists says the discovery of an electrically charged subatomic particle called Zc(4020) is ...

NASA's TRMM satellite sees Super-typhoon Haiyan strike Philippines

2013-11-09
NASA's TRMM satellite sees Super-typhoon Haiyan strike Philippines VIDEO: NASA's TRMM satellite data on Nov. 8 at 00:19 UTC showed Haiyan had a well-defined eye surrounded ...

Snap to attention: Polymers that react and move to light

2013-11-09
Snap to attention: Polymers that react and move to light PITTSBURGH—Microvehicles and other devices that can change shape or move with no power source other than a beam of light may be possible through research led by the University of Pittsburgh. The researchers are ...

New therapeutic target identified for ALS and frontotemporal degeneration

2013-11-09
New therapeutic target identified for ALS and frontotemporal degeneration A team of scientists led by researchers from the University of California, San Diego School of Medicine and Ludwig Institute for Cancer Research have identified a novel therapeutic approach ...

Montana State team overcomes challenges, proves that microbes swim to hydrogen gas

2013-11-09
Montana State team overcomes challenges, proves that microbes swim to hydrogen gas BOZEMAN, Mont. – Scientists have long believed that microorganisms that produce methane swim toward the hydrogen gas they need to stay alive, but it has been too hard to prove in ...

Sun unleashes another X-class flare

2013-11-09
Sun unleashes another X-class flare The sun emitted its sixth significant flare since Oct. 23, 2013, peaking at 11:26 p.m. EST on Nov. 7, 2013. Solar flares are powerful bursts of radiation. Harmful radiation from a flare cannot pass through Earth's ...

Hubble catches stellar explosions in NGC 6984

2013-11-09
Hubble catches stellar explosions in NGC 6984 Supernovae are intensely bright objects. They are formed when a star reaches the end of its life with a dramatic explosion, expelling most of its material out into space. The subject of this new Hubble ...

JCI early table of contents for Nov. 8, 2013

2013-11-08
JCI early table of contents for Nov. 8, 2013 Ion channel inhibition limits injury-induced loss of kidney filtration The kidney is responsible for retaining essential proteins and removing waste products from the blood stream. Injury to the kidney results ...

LAST 30 PRESS RELEASES:

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

Defensive firearm use is far less common than exposure to gun violence

Lifetime and past-year defensive gun use

Lifetime health effects and cost-effectiveness of tirzepatide and semaglutide in US adults

[Press-News.org] Gene hastens kidney disease progression in African-Americans